Information Provided By:
Fly News Breaks for April 14, 2016
DXCM
Apr 14, 2016 | 16:25 EDT
BTIG analyst Sean Lavin initiated Dexom with a Buy rating and $80 price target. The analyst views the pullback as a buying opportunity and said the continuous glucose monitor is currently underpenetrated and Dexcom is strategically positioned to gain share.
News For DXCM From the Last 2 Days
There are no results for your query DXCM